Brevan Howard Capital Management LP Amneal Pharmaceuticals, Inc. Transaction History
Brevan Howard Capital Management LP
- $13.9 Billion
- Q4 2024
A detailed history of Brevan Howard Capital Management LP transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 13,571 shares of AMRX stock, worth $114,403. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,571Holding current value
$114,403% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding AMRX
# of Institutions
205Shares Held
123MCall Options Held
362KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA14.8MShares$125 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$104 Million2.69% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$95.1 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$90.4 Million1.4% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il8.98MShares$75.7 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.28B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...